Your search has returned 30 results.
The Medical Research Council and the National Institute for Health Research, in partnership with the Global Alliance for Chronic Diseases (GACD), are seeking to generate new knowledge on interventions and their implementation for the prevention of cancer in low and middle income countries (LMIC).
The CRTF supports clinically active professionals within the UK to undertake a higher research degree. The scheme can also provide post-doctoral funding for applicants who achieved their PhD more than five years ago but who have not been research active since due to clinical training commitments.
The CSF develops talented medically and other clinically qualified professionals who have gained a higher research degree to lead their own research plans and establish their own research team to make the transition to independent investigator.
The CDA supports talented post-doctoral researchers to lead their own research plans and establish their own research team to make the transition from post-doctoral researcher to independent investigator.
The SNCF supports proven independent researchers with an effective track record of internationally competitive independent research to make the transition to research leadership.
You can apply to the Population & Systems Medicine Board through four of our grant schemes.
This call funds late-stage clinical and health intervention trials evaluating efficacy and effectiveness that will contribute to the improvement of health in low and middle income countries (LMICs). Applicants based at eligible research organisations in LMICs and the UK are eligible to apply.
Please note: the trial development grant funding opportunity will be launched in October 2020.
In 2019 the Medical Research Council (MRC) in partnership with the National Institute for Health Research (NIHR) ran two pilot rounds of the Clinical Academic Research Partnerships (CARP) scheme.The response to this scheme was overwhelmingly positive and a commitment has been made to launch Round 3 of CARP in August 2020.